Oncopeptides AB
OTC:ONPPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncopeptides AB
OTC:ONPPF
|
SE |
|
T
|
Toyo Kanetsu KK
F:TQ2
|
JP |
|
ANA Holdings Inc
OTC:ALNPF
|
JP |
|
Revive Therapeutics Ltd
OTC:RVVTF
|
CA |
|
M
|
Mgi Digital Technology SA
LSE:0D00
|
FR |
|
S
|
sino AG
SWB:XTP
|
DE |
|
M
|
Metro Mining Ltd
F:6ME
|
AU |
|
Frontier Nuclear and Minerals Inc
NASDAQ:FNUC
|
CA |
|
R
|
Rokiskio Suris AB
SWB:YTV
|
LT |
|
Spruce Biosciences Inc
NASDAQ:SPRB
|
US |
|
Oryzon Genomics SA
MAD:ORY
|
ES |
|
B
|
BBI Development SA
WSE:BBD
|
PL |
|
M
|
MetLife Inc
F:MWZ
|
US |
|
W
|
Wintest Corp
TSE:6721
|
JP |
|
E
|
Enagas SA
XMUN:EG4
|
ES |
|
Croma Security Solutions Group PLC
LSE:CSSG
|
UK |
|
M
|
MetLife Inc
XMUN:MWZ
|
US |
|
D
|
DBS Group Holdings Ltd
XBER:DEVL
|
SG |
|
P
|
Principal Financial Group Inc
XMUN:PG4
|
US |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
Multiples-Based Value
The Multiples-Based Value for
Oncopeptides AB (ONPPF) under the Base Case is hidden
USD.
Compared with the current market price of 0.265 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.